Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000726499 | SCV000345083 | uncertain significance | not provided | 2016-08-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000328069 | SCV000528873 | likely benign | not specified | 2016-07-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV002059293 | SCV002388080 | benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000726499 | SCV004010719 | likely benign | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | FLNC: BS1 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000328069 | SCV004223183 | benign | not specified | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000328069 | SCV001921131 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000726499 | SCV001927760 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000726499 | SCV001958261 | likely benign | not provided | no assertion criteria provided | clinical testing |